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Cellular/Molecular
Cyclin-Dependent Kinase 5 Phosphorylates the N-Terminal
Domain of the Postsynaptic Density Protein PSD-95
in Neurons
Maria A. Morabito,1 Morgan Sheng,2 and Li-Huei Tsai3
1Department of Pathology, Harvard Medical School, Boston, Massachusetts 02115, 2Picower Center for Learning and Memory, RIKEN-MIT Neuroscience
Research Center, Howard Hughes Medical Institute, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, and 3Department of
Pathology and Howard Hughes Medical Institute, Harvard Medical School, Boston, Massachusetts 02115
PSD-95 (postsynaptic density 95) is a postsynaptic scaffolding protein that links NMDA receptors to the cytoskeleton and signaling
molecules. The N-terminal domain of PSD-95 is involved in the synaptic targeting and clustering of PSD-95 and in the clustering of NMDA
receptors at synapses. The N-terminal domain of PSD-95 contains three consensus phosphorylation sites for cyclin-dependent kinase 5
(cdk5), a proline-directed serine-threonine kinase essential for brain development and implicated in synaptic plasticity, dopamine
signaling, cocaine addiction, and neurodegenerative disorders.
We report that PSD-95 is phosphorylated in the N-terminal domain by cdk5 in vitro and in vivo, and that this phosphorylation is not
detectable in brain lysates of cdk5/mice. N-terminal phosphorylated PSD-95 is found in PSD fractions together with cdk5 and its
activator, p35, suggesting a role for phosphorylated PSD-95 at synapses. In heterologous cells, coexpression of active cdk5 reduces the
ability of PSD-95 to multimerize and to cluster neuronal ion channels, two functions attributed to the N-terminal domain of PSD-95.
Consistent with these observations, the lack of cdk5 activity in cultured neurons results in larger clusters of PSD-95. In cdk5/ cortical
neurons, more prominent PSD-95 immunostained clusters are observed than in wild-type neurons. In hippocampal neurons, the expres-
sion of DNcdk5 (inactive form of cdk5) or of the triple alanine mutant (T19A, S25A, S35A) full-length PSD-95 results in increased PSD-95
cluster size.
These results identify cdk5-dependent phosphorylation of the N-terminal domain of PSD-95 as a novel mechanism for regulating the
clustering of PSD-95. Moreover, these observations support the possibility that cdk5-dependent phosphorylation of PSD-95 dynamically
regulates the clustering of PSD-95/NMDA receptors at synapses, thus providing a possible mechanism for rapid changes in density and/or
number of receptor at synapses.
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Introduction
PSD-95/SAP-90 (synapse-associated protein-90) is a member of
the membrane-associated guanylate kinase (MAGUK) family of
proteins that has been implicated in the assembly of many com-
ponents of the postsynaptic density (PSD) (Craven and Bredt,
1998; El-Husseini et al., 2000b; Garner et al., 2000; Kennedy,
2000; Lee and Sheng, 2000; Sheng and Pak, 2000; Craig and Bou-
din, 2001; McGee and Bredt, 2003). PSD-95 localizes and clusters
at synapses early during synapse formation, suggesting that
PSD-95 plays a primary role in organizing and localizing proteins
to the PSD (Rao et al., 1998), and thus contributes to synapse mat-
uration (El-Husseini et al., 2000b). PSD-95 contains distinct struc-
tural domains such as three PDZ [PSD-95/Discs large (Dlg)/zona
occludens-1 (ZO-1)] protein interaction motifs, an Src homology 3
(SH3) domain, and a C-terminal guanylate kinase domain. The PDZ
domains of PSD-95 interact directly with intracellular signaling
components (Brenman et al., 1996a; Chen et al., 1998; Kim et al.,
1998), putative cell adhesion molecules (Irie et al., 1997), Shaker-
type K channel (Kim et al., 1995), and NMDA receptors
(NMDARs) (Kornau et al., 1995). Therefore, mechanisms that reg-
ulate synaptic clustering of PSD-95 may be fundamental to postsyn-
aptic differentiation and efficacy of synaptic transmission. The N-
terminal domain of PSD-95 is essential for synaptic targeting and
clustering of PSD-95 in neurons (Craven et al., 1999). The N-
terminal domain of PSD-95 is palmitoylated (Milligan et al., 1995;
Mumby, 1997; Topinka and Bredt, 1998), and this post-translational
modification is required for its intracellular sorting, postsynaptic
targeting, and ion channel clustering (Hsueh et al., 1997; Topinka
and Bredt, 1998; Craven et al., 1999; El-Husseini et al., 2000a).
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We investigated the possibility that the phosphorylation of
PSD-95 may also have an impact on its function. The N-terminal
domain of PSD-95 contains three serine/threonine proline
dipeptide motifs, which constitute minimal cyclin-dependent ki-
nase 5 (cdk5) consensus phosphorylation sites (Beaudette et al.,
1993; Songyang et al., 1996; Dhavan and Tsai, 2001). Cdk5 is a
proline-directed serine/threonine kinase essential for brain de-
velopment (Dhavan and Tsai, 2001). Cdk5 is active only when
associated with one of its activators: p35 or its homolog p39.
Cdk5-deficient mice and p35/p39 double knock-out mice die
between late embryonic and perinatal stages (Ohshima et al.,
1996; Ko et al., 2001). Cdk5, p35, and p39 are enriched in synaptic
membranes and localize to postsynaptic compartments (Hum-
bert et al., 2000; Niethammer et al., 2000). Recently, cdk5 has
been shown to phosphorylate NR2A, a subunit of the NMDA
receptor (NMDAR), which in turn influences long-term poten-
tiation (LTP) induction in hippocampal neurons (Li et al., 2001).
Using phospho-specific antibodies, we find that the N-terminal
domain of PSD-95 is phosphorylated in vivo in a cdk5-dependent
manner. We report that cortical neurons lacking cdk5 activity
(cdk5/mutants) as well as hippocampal neurons expressing
inactive cdk5 (DNcdk5) or the alanine mutant of PSD-95 have
enlarged PSD-95 clusters. These studies indicate that phosphor-
ylation by cdk5 may negatively regulate the clustering of PSD-95
and NMDAR at synapses, thus implicating cdk5 in the regulation
of synapse formation and synaptic plasticity.
Materials and Methods
DNA constructs. PSD-95 bacterial and mammalian expression constructs
have been described previously (Hsueh et al., 1997). Mutagenesis of
PSD-95 was performed by PCR amplification using Vent (New England
Biolabs, Beverly, MA) and the appropriate oligonucleotides. All muta-
tions were confirmed by sequencing. The mammalian constructs were
expressed using the mammalian expression vectors GW1 or pcDNA3.
Kinase assays. The bacterial constructs were expressed in BL-21 and the
recombinant His-tagged proteins purified using Ni-NTA agarose ac-
cording to the manufacturer (Qiagen, Hilden, Germany). Bacterially
produced histidine-tagged proteins were incubated with the p35-cdk5
kinase (immunoprecipitated from rat brain lysate) for 30 min at room
temperature in the presence of [ 32P ATP] as described previously (Ni-
kolic et al., 1996). Alternatively, recombinant glutathione S-transferase
(GST)-cdk5 and GST-p25 were incubated at room temperature for 20
min and then incubated in a 1:1:1 molar ratio (or with increasing
amounts) of recombinant histidine-tagged proteins for increasing
amounts of time (or for 5 min) in the presence of 0.033 103 mM [ 32P
ATP] and 0.1 mM ATP. Ten percent of the samples were separated on 12
or 15% polyacrylamide gel, Coomassie stained, and autoradiographed
or, alternatively, analyzed by PhosphorImager (Molecular Dynamics,
Sunnyvale, CA) using ImageQuant.
Brain fractionations. All buffers contained a cocktail of protease and
phosphatase inhibitors (1 mM PMSF, 1 g/ml aprotinin, 10 g/ml leu-
peptin, 1 g/ml pepstatin, 1 mM Na3VO4, 50 mM NaF). Rat brain crude
synaptosomal fraction (P2) and subcellular fractions were prepared as
described previously (Huttner et al., 1983; Niethammer et al., 2000).
Synaptosomal fractions were lysed in 150 mM NaCl, 10 mM Tris, pH 8.0,
and 1 mM EDTA with 1% SDS, followed by the addition of five volumes
of 2% Triton X-100, 150 mM NaCl, 10 mM Tris, pH 8.0, and 1 mM EDTA
and used for p35 coimmunoprecipitations, or lysed with 1% Triton
X-100, 150 mM NaCl, 10 mM Tris, pH 8, and 1 mM EDTA and used for
Western blot analysis. Alternatively, synaptosomal fractions were lysed in
radioimmunoprecipitation assay (RIPA) buffer and used for NR2B co-
immunoprecipitation. Purified PSD fractions were prepared from rat
brain lysate and subjected to detergent extraction as described previously
(Cho et al., 1992). Synaptosomal fractions were extracted in 150 mM
NaCl, 10 mM Tris, pH 8.0, and 1 mM EDTA in the presence of 0.5% NP-40
or 1% Triton X-100 and centrifuged at 100,000  g. Pellets and super-
natants were analyzed by SDS-PAGE and Western blot.
Phospho-epitope-specific antibodies. Phospho-epitope-specific anti-
serum against phosphorylated T19 and S25 PSD-95 was raised in rabbit
using the synthetic phospho-peptide QDEDTPPLEHSPAH (Tufts Med-
ical School, Boston, MA). The resulting antiserum was first purified from
nonphosphorylated synthetic peptide coupled to a Sulfolink column
(Pierce Biotechnology, Rockford, IL) and then affinity-purified over the
phosphorylated T19 and S25 synthetic peptide linked to a Sulfolink col-
umn, according to the manufacturer’s recommendation.
Immunoprecipitations and Western blotting. All buffers contained a
cocktail of protease and phosphatase inhibitors (1 mM PMSF, 1 g/ml
aprotinin, 10 g/ml leupeptin, 1 mM Na3VO4, and 50 mM NaF). The
brains of mice lacking p35, or both p35 and p39, or wild-type, were lysed
in RIPA buffer. Adult rat brains were lysed in 150 mM NaCl, 50 mM Tris,
pH 7.5, and 5 mM EDTA and immunoprecipitations were performed
using anti-PSD-95 antibody (Upstate Biotechnology, Lake Placid, NY) or
anti-Myc antibody (Oncogene, San Diego, CA) as control. COS-7 cells
were lysed in RIPA buffer and immunoprecipitations were performed
from transfected COS-7 cell lysates using anti-Myc antibody (Onco-
gene), or anti PSD-95-CSK, or anti-Kv1.4 antibodies. Complexes were
isolated using protein A or protein G Sepharose. Tissue and cell lysates
were separated by SDS-PAGE, transferred to Immobilon polyvinylidene
difluoride membranes (Millipore, Billerica, MA) and immunoblotted
with phospho-T19S25 antibody, anti-HA antibody (Santa Cruz Biotech-
nology, Santa Cruz, CA), anti-Myc antibody (Oncogene), anti-PSD-95
(Upstate Biotechnology), anti-Kv1.4, anti-p35 (Santa Cruz), and anti-
cdk5 (Santa Cruz).
Cell cultures. COS-7 cells were maintained in DMEM supplemented
with 10% fetal calf serum and transiently transfected with various plas-
mid constructs using Lipofectamine 2000 (Invitrogen, Grand Island,
NY) according to the manufacturer’s instructions. Cells were collected
16 –20 hr after transfection.
Neuronal cultures. Pregnant animals were killed in accordance with
institutional guidelines and as approved by the animal care and use com-
mittee. For cdk5/ cultures, cortical neurons derived from embryonic
day 16.5 (E16.5) brains were plated on coverslips coated with poly-L-
lysine at a density of 3.2 10 3/coverslip and grown in neuronal condi-
tioned Neurobasal medium (Invitrogen) supplemented with B27 (In-
vitrogen) and L-glutamine (Brewer et al., 1993). Neurons were fixed for
immunostaining at 4 d in vitro (DIV).
Primary hippocampal cultures were prepared from E17–E18 rat brains
and grown in Neurobasal medium supplemented with B27 and
L-glutamine. Neurons were plated on poly-D-lysine and laminin at a
density of 30,000/coverslip. Wild-type or phosphorylation mutant
(T19A, S25A, S35A) full-length PSD-95 together with GFP were trans-
fected after 14 DIV using Lipofectamine-2000 according to the manufac-
turer’s instructions. Neurons were fixed and analyzed 16 –20 hr after
transfection. For the herpes simplex virus (HSV) infection experiments,
neurons were plated on coverslips coated with poly-L-lysine at a density
of 30,000/coverslip. Infections were performed using recombinant HSV
expressing DNcdk5-GFP or LacZ (a gift from R. Neve, McLean Hospital,
Belmont, MA) as described previously (Nikolic et al., 1996, 1998). Mul-
tiplicity of infection ranged from 0.1 to 1. The efficiency of infection
ranged from 28 to 70%, depending on the HSV preparation. Neurons
were fixed for immunostaining 18 –20 hr after infection.
Immunostaining. COS-7 cells were fixed in 4% paraformaldehyde for
20 min at room temperature followed by permeabilization with 0.1%
Triton X-100 and 10% BSA in PBS. Hippocampal and cortical neurons
were fixed in20°C methanol for 10 min, followed by permeabilization
with 0.2% Triton X-100 and 10% BSA in PBS. Hippocampal neurons
used for p35 and PSD-95 immunostaining were fixed in 4% paraformal-
dehyde for 20 min at room temperature. Immunostaining was per-
formed using anti-PSD-95 (guinea pig anti-PSD-95; M. Sheng), anti-
Kv1.4 (M. Sheng), anti-NR1 (PharMingen International, San Diego,
CA), and anti-p35 (Santa Cruz). Coverslips were mounted in ProLong
antifade (Molecular Probes, Eugene, OR) and analyzed using Nikon (To-
kyo, Japan) Delta Vision microscopy. Cortical cultures were analyzed
blind by Carl Zeiss (Oberkochen, Germany) Axiovert 100M confocal
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microscopy using a 25 objective. TOTO-3 Io-
dide (Molecular Probes) was used to stain nu-
clei. PSD-95 immunostaining were quantified
blind using Metamorph (Downingtown, PA)
software using a threshold of 90. A total of 32
hippocampal neurons transfected with wild-
type full-length PSD-95 and 32 hippocampal neu-
rons transfected with mutant (T19A, S25A, S35A)
full-length PSD-95 were analyzed blind by Zeiss
confocal microscopy. PSD-95 immunostaining
was quantified blind using Metamorph software
at a threshold of 120. Infected hippocampal neu-
rons were analyzed using Nikon Delta Vision
microscopy. A total of 431 (infected with HSV-
DNcdk5-GFP) and 371 (infected with HSV-
LacZ) PSD-95 immunoreactive regions derived
from 14 and 8 dendrites, respectively, were ana-
lyzed blind by Metamorph software using a
threshold of 94. The areas of immunostaining
were rendered in number of pixels. The statistical
significance of this analysis was determined using
the unpaired t test.
Results
PSD-95 is a substrate of the
p35-cdk5 kinase
The N-terminal region of PSD-95 contains
three cdk5 consensus phosphorylation sites,
suggesting the possibility that PSD-95 is a
substrate of cdk5. Three additional potential
phosphorylation sites are within the linker
region between the second and third PDZ
motif. p35 and cdk5 are present in the PSD
(Niethammer et al., 2000), and p35 colo-
calizes with PSD-95 along the dendrites of
primary hippocampal neurons (Fig. 1A).
An interaction between p35-cdk5 and
PSD-95 is supported by the association of
p35 and PSD-95 in synaptosomes, as de-
tected by coimmunoprecipitation of
PSD-95 with a p35 antibody (Fig. 1B).
To investigate whether the interaction
between p35 and PSD-95 results in phos-
phorylation of PSD-95 by cdk5, 6
histidine-tagged PSD-95 recombinant
proteins were used as substrates for in vitro
kinase assays using either p35-cdk5 immu-
noprecipitated from brain (Fig. 1D), or ki-
nase reconstituted from recombinant
GST-cdk5 and GST-p25 (Fig. 1E). Dele-
tion mutants Myc-N-PDZ1–2S-His, Myc-
N-PDZ1-His, and Myc-N-His contain
only the N-terminal three potential cdk5
phosphorylation sites, T19, S25, and S35
(Fig. 1C,D) (Hsueh et al., 1997). These fu-
sion proteins were readily phosphorylated
by immunoprecipitated p35-cdk5 in vitro
to a extent similar to that of histone H1, a
generic substrate of cdk5 (Fig. 1D). To ex-
clude the possibility that other coimmu-
noprecipitated kinases may contribute to
the phosphorylation, an in vitro kinase
assay was performed using cdk5 recon-
stituted from recombinant GST-cdk5
and GST-p25. Myc-N-PDZ1-His or his-
Figure 1. PSD-95 associates with p35 and is an in vitro substrate of p35-cdk5. A, Colocalization of p35 and PSD-95 along
dendrites of hippocampal neurons. Hippocampal neurons (14 DIV) were fixed and immunostained for p35 and PSD-95. Scale bar,
10m. B, Coimmunoprecipitation of p35 and PSD-95 from synaptosome lysates. Synaptosomes were lysed in the presence of 1%
SDS, and immunoprecipitations were performed using polyclonal p35 antiserum, antiserum preabsorbed with p35 antigen, or
preimmune serum. C, Constructs used and the amino acid sequence of the N-terminal domain of PSD-95. All constructs contain the
N-terminal domain with the three cdk5 consensus phosphorylation sites (T19, S25, S35). D, In vitro kinase assay using p35-cdk5
immunoprecipitated from brain. N, N-PDZ1, and N-PDZ1–2S were bacterially expressed as Myc–His-tagged proteins and 1g of
each protein was used as a substrate in an in vitro kinase assay using p35-cdk5 immunoprecipitated from brain. Histone H1 (H1),
a generic substrate of p35-cdk5, was used as positive control. The white arrowheads indicate the recombinant proteins; the black
arrowhead indicates autophosphorylated p35. The Coomassie staining indicates the amount of proteins used. E, In vitro kinase
assay using purified reconstituted recombinant cdk5 kinase. Left, GST-p25, GST-cdk5, and substrate (either N-PDZ1 or histone H1
as control) were added to the reaction to a final concentration of 6.6 107 M. The kinetics of the reactions were determined by
analyzing the incorporation of 32P ATP after increasing incubation periods. Right, Increasing amounts of N-PDZ1 or histone H1
were used as substrates in the in vitro kinase reaction with reconstituted recombinant cdk5. The reaction was stopped after 5 min
by adding sample buffer. F, In vitro kinase assay of PSD-95 mutants. N-PDZ1 mutants (T19A, S25A, and T19A S25A) were expressed
as His-tagged proteins in bacteria and 1g of each was used in an in vitro kinase assay using p35-cdk5 kinase immunoprecipitated
from brain. The mutant proteins are not Myc-tagged, and they display a faster mobility on SDS-PAGE. The wild-type recombinant
protein and the mutant proteins are indicated by the white and black arrows, respectively, and the arrowhead indicates auto-
phosphorylated p35.
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tone H1 were used as substrates and the
reactions were performed with a 1:1:1
stoichiometry of GST-p25, GST-cdk5,
and Myc-N-PDZ1-His or histone H1
(Fig. 1 E, left). The phosphorylation of
Myc-N-PDZ1-His, similar to histone
H1, can be detected as early as 2–5 min
after the start of the reactions. However,
when increasing amounts of substrate
were used and the kinase assays were
performed for only 5 min, 32PATP in-
corporation increased proportionally to
the increase in recombinant Myc-N-
PDZ1-His protein added to the reaction,
further supporting the specificity of the
phosphorylation (Fig. 1 E, right). To fur-
ther confirm PSD-95 as an in vitro sub-
strate of cdk5, the stoichiometry of the
reaction was calculated by using recom-
binant p25-cdk5. ATP (58.468 pmol)
was incorporated into recombinant
Myc-N-PDZ1–2S-His (67.7 pmol) after
1 hr, to a stoichiometry of 0.863, compa-
rable with the stoichiometry of the phos-
phorylation of protein phosphatase in-
hibitor-1 by cdk5 (Bibb et al., 2001).
Together, these experiments indicate
that the N-terminal domain of PSD-95 is
a specific substrate of cdk5 in vitro.
Among the three potential phosphoryla-
tion sites in the N-terminal region of
PSD-95, S25 (SPAH) is an optimal cdk5
phosphorylation site (Fig. 1C). To inves-
tigate which of the three sites (T19, S25,
and S35) is phosphorylated by cdk5, an
in vitro p35-cdk5 kinase assay was per-
formed using alanine substitution mu-
tants of N-PDZ1-His proteins and p35-
cdk5 immunoprecipitated from brain.
In this assay, the single mutant T19A was
phosphorylated by cdk5, although to a
much lesser extent than the wild-type
protein, whereas the S25A and the T19A
S25A mutants were not phosphorylated
to detectable levels (Fig. 1 F). The ob-
served difference in migration between
mutant and wild-type proteins is caused by the absence of the
Myc tag in the mutants. These results indicate that S25 and
T19 are in vitro phosphorylation sites and S25 is the primary
target of phosphorylation by cdk5.
To evaluate whether T19 and S25 are phosphorylated in vivo,
a phospho-epitope-specific antibody (phospho-T19S25) was
raised against a synthetic peptide containing both phospho-T19
and phospho-S25 (Fig. 2A). Phospho-T19S25 antibody recog-
nized endogenous PSD-95 immunoprecipitated from rat brain
lysates by a monoclonal PSD-95 antibody (Fig. 2B). The
phospho-T19S25 antibody recognizes the band with the second
slower mobility (Fig. 2C). The specificity of the purified
phospho-T19S25 antibody was verified by treatment with calf
intestine phosphatase (CIP) of immunoprecipitated PSD-95.
This treatment reduced the ability of the phospho-T19S25 anti-
body to recognize PSD-95 (Fig. 2C). In addition, the specificity of
the antibody was tested by Western blotting of COS-7 cell lysates
coexpressing truncated PSD-95 (N-PDZ1–2S) and p35-cdk5. Al-
though phospho-T19S25 antibody hardly detected PSD-95 when
expressed alone, it generated a robust signal in lysates from cells
expressing PSD-95 and p35-cdk5 (Fig. 2D). Preabsorption of this
antibody with the antigenic peptide completely abolished the
ability of the phospho-T19S25 antibody to recognize PSD-95
(Fig. 2D). To further determine the specificity of the phospho-
T19S25 antibody, T19A and S25A N-PDZ1–2S mutants were ex-
pressed in COS-7 cells in the absence or presence of p35-cdk5.
Western blot analysis of lysates reveals that although the
phospho-T19S25 antibody detected a strong PSD-95 signal in
lysates expressing wild-type protein, the signal was abolished
in lysates expressing the S25A mutant and was markedly re-
duced in lysates expressing the T19A mutant (Fig. 2 E). To-
gether, these data indicate that the phospho-T19S25 antibody
recognizes both phospho-T19 and phospho-S25, with phospho-
S25 likely to be the major recognition epitope.
Figure 2. PSD-95 is phosphorylated in vivo in a p35-cdk5-dependent manner. A, Sequence of the peptide used to raise the
phospho-epitope-specific antibody. T19 and S25 are both phospho-residues. B, Western blot of endogenous PSD-95 using the
phospho-T19S25 antibody. Endogenous PSD-95 was immunoprecipitated with PSD-95 antibody from rat brain lysates and blot-
ted with phospho-T19S25 antibody. Myc immunoprecipitation was used as a control; 3% of lysates was loaded as input. C, CIP
treatment of immunoprecipitated PSD-95. PSD-95 was immunoprecipitated from rat brain lysate and the immunoprecipitate was
treated or untreated with CIP and analyzed by Western blot with phospho-T19S25 antibody. D, Western blot of COS-7 cell lysates
expressing truncated PSD-95 (N-PDZ1–2S) in the presence (or absence) of p35-cdk5 kinase. The blot was probed with phospho-
T19S25 antibody. Antibody preabsorbed with the phospho-peptide (phosphorylated T19 and S25) was used as a control. The blot
was probed with PSD-95 antibody to control for loading. E, Western blot of COS-7 cell lysates expressing PSD-95 mutants (T19A or
S25A) in the presence (or absence) of p35-cdk5. The blot was probed with phospho-T19S25 antibody and subsequently probed
with PSD-95, p35, and cdk5 antibodies. F, Western blot of rat synaptosomal lysates. The lysates were immunoblotted for phospho-
T19S25 antibody, or phospho-T19S25 antibody preabsorbed with the phospho-peptide. PSD-95 antibody was used as control for
loading. G, Western blot of E17 mutant and wild-type mouse brain lysates. The phosphorylation on T19 and S25 of endogenous
PSD-95 was evaluated in brain lysates of wild-type, p35/ p39/, or p35/ p39/mice. Lysates were immuno-
blotted with phospho-T19S25 antibody and subsequently probed for PSD-95 as a loading control.
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In synaptosomal fractions from rat brain lysates, the
phospho-T19S25 antibody detected a single band of the expected
molecular weight for PSD-95, whereas no immunoreactive band
was observed when the antibody was preabsorbed with the
phospho-peptide used as antigen (Fig. 2). A slower migrating
form of PSD-95 not recognized by the phospho-T19S25 antibody
was also observed (Fig. 2F), possibly representing a product of
other post-translational modifications or the alternatively spliced
isoform of PSD-95 (Chetkovich et al., 2002). These results sug-
gest that PSD-95 is phosphorylated on T19, S25, or both, in vivo.
In addition, they indicate that the phospho-T19S25 antibody is
highly specific to phosphorylated PSD-95 in synaptosomes. To
verify that the phosphorylation of PSD-95 was dependent on
cdk5 activity, the contribution of cdk5 to the phosphorylation of
endogenous PSD-95 was evaluated in brain lysates derived from
E17 p35/ and p35/ p39/ mice. Reduced phospho-
T19-S25 immunoreactivity was observed in p35/ lysates, and
no strong signal was detected in lysates of p35/p39/mice,
which lack cdk5 activity (Fig. 2G), although comparable levels of
PSD-95 were present in mutant and wild-type brains (Fig. 2G).
These observations strongly suggest that PSD-95 is a physiologi-
cal substrate of cdk5.
Phosphorylated PSD-95 is present in the PSD
PSD-95 is a protein targeted to synapses and enriched at the PSD.
To assess the subcellular distribution of phosphorylated PSD-95,
biochemical fractionation of adult brain lysates was performed
(Fig. 3A). PSD-95 was abundant in the crude synaptosomal frac-
tion (P2) and in the synaptosomal membrane fraction (LP1).
Overall, the subcellular distribution of phospho-PSD-95 was
reminiscent of that of total PSD-95. Because PSD-95 is abundant
in PSD fractions (Cho et al., 1992), these fractions were analyzed
for the presence of phosphorylated PSD-95. The phosphorylated
form of PSD-95 was enriched in PSD fraction II and in the core of
PSD (fraction III) (Fig. 3B). This distribution pattern resembled
that of p35 and cdk5 (Fig. 3B), consistent with the possibility that
phosphorylation of PSD-95 occurs postsynaptically and that it
plays a role in synaptic function. PSD-95 is an itinerant vesicular
protein, and its association with membranes mediates its intra-
cellular trafficking (El-Husseini et al., 2000a). To investigate the
possibility that phosphorylation of the N-terminal domain of
PSD-95 may alter its association with membranes, synaptosomal
membranes were extracted with non-ionic detergents and the
derived fractions analyzed by western blot (Fig. 3C). Phosphory-
lated PSD-95 was more readily extracted than the total PSD-95;
25.27% of total PSD-95 was soluble in 0.5% NP-40 and 13.74% in
1% Triton X-100. In contrast, as detected by the phospho-
T19S25 antibody, 68.50% of phosphorylated PSD-95 was soluble
in 0.5% NP-40 and 45.46% in 1% Triton X-100. The increased
extractability of phosphorylated PSD-95 versus total PSD-95 sug-
gests that the phosphorylation of the N terminal of PSD-95 re-
sults in a weaker attachment of PSD-95 to membranes compared
with the unphosphorylated form.
Phosphorylation regulates PSD-95 multimerization but not
neuronal ion channel binding
PSD-95 functions as a scaffolding protein that organizes large
protein complexes at synapses. The N-terminal domain of
PSD-95 mediates its multimerization (Hsueh et al., 1997),
whereas the first two PDZ domains bind specifically to the C
terminal of Shaker-type K channels (Kv1.4) and of NR2 sub-
units of NMDARs (Kim et al., 1995; Kornau et al., 1995;
Niethammer et al., 1996). To investigate whether phosphoryla-
tion of the N-terminal domain of PSD-95 affects association of
PSD-95 with ion channels, coimmunoprecipitations were per-
formed from lysates of COS-7 cells coexpressing N-PDZ1–2S and
Kv1.4, in the presence or absence of p35-cdk5. In these lysates,
phosphorylation of PSD-95 by p35-cdk5 was evident from the
Figure 3. Phosphorylated PSD-95 is present in synaptosomal membrane fraction LP1 and in
PSD fractions. A, Western blot of subcellular fractions of rat brain lysates. The blot was probed
with phospho-T19S25 antibody and, subsequently, with antibodies for PSD-95, synaptophysin
(SVP38), p35, and cdk5. H, Brain lysate; P2, crude synaptosomal fraction; S2, cytosol and light
membranes; P3m light membranes (Golgi and ER); S3, cytosolic fraction; LP1, synaptosomal
membrane fraction; LS1, synaptosomal cytosol; LP2, vesicles and small membrane fractions;
LS2, supernatant of LP2. B, Western blot of PSD fractions. PSD fractions were prepared from P2
by differential and density gradient centrifugation followed by extraction once with Triton
X-100 ( I ), twice with Triton X-100 (II), or once with Triton X-100 and once with N-lauroyl-
sarcosine (III). Fraction III represents the core of PSD. One microgram of protein was loaded for
each fraction of the PSD. The blot was probed with phospho-T19S25 antibody and, subse-
quently, with antibodies for PSD-95, p35, and cdk5. C, Detergent extractions of synaptosomal
fractions. Crude synaptosomal fractions were extracted with either 0.5% NP-40 or 1% Triton
X-100 followed by 100,000 g centrifugation. The soluble and pellet fractions were blotted
with phospho-T19S25 antibody and, subsequently with PSD-95 antibody.
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presence of the slower-migrating species
of PSD-95. An antibody against Kv1.4 co-
immunoprecipitated PSD-95, regardless
of p35-cdk5 expression (Fig. 4 A, top).
This result suggests that phosphorylation
of the N-terminal domain of PSD-95 does
not disrupt the association of PSD-95 with
Kv1.4. In addition, in synaptosomal ly-
sates, phosphorylated PSD-95 is coimmu-
noprecipitated by an antibody against
NR2B, a subunit of the NMDAR that binds
specifically to the first two PDZ domains
of PSD-95, as detected by phospho-
T19S25 antibody (Fig. 4A, bottom). To-
gether, these observations support the
possibility that PSD-95 binds neuronal ion
channels irrespective of the phosphoryla-
tion of the N-terminal domain of PSD-95.
Because the N-terminal domain of PSD-95
has been implicated in the multimeriza-
tion of PSD-95, it is possible that the phos-
phorylation of this region of PSD-95 by
cdk5 may affect the self-association of
PSD-95. This possibility was tested in
COS-7 cells using PSD-95 constructs that
are either of different size or have a differ-
ent epitope tag. In one set of experiments,
COS-7 cells were cotransfected with Myc-
tagged full-length PSD-95 (Myc-PSD-95),
untagged N-PDZ1–2S, and with or without
p35-cdk5. As predicted, the anti-Myc an-
tibody, which recognizes only the full-
length PSD-95, coimmunoprecipitated
N-PDZ1–2S in the absence of p35-cdk5.
However, when p35 and cdk5 were co-
expressed, coimmunoprecipitation of
N-PDZ1–2S with Myc-PSD-95 by the
anti-Myc antibody was drastically
reduced (Fig. 4B), suggesting that phos-
phorylation of N-PDZ1–2S and Myc-
PSD-95 by p35-cdk5 decreases PSD-95
multimerization. This observation was
confirmed using two differentially tagged
full-length PSD-95 constructs, either HA- or
Myc-tagged (HA-PSD-95 and Myc-PSD-
95, respectively). The anti-Myc antibody co-
immunoprecipitated HA-PSD-95 with
Myc-PSD-95 in the absence of p35-cdk5
(Fig. 4C). However, when p35 and cdk5
were coexpressed, coimmunoprecipita-
tion of HA-PSD-95 with Myc-PSD-95 was
markedly reduced (Fig. 4C). To verify that
the phosphorylation of the N-terminal do-
main of PSD-95 by p35-cdk5 was respon-
sible for the observed reduction of PSD-95
multimerization, the triple alanine phos-
phorylation mutants (T19A, S25A, S35A)
of full-length PSD-95 (AAA PSD-95) and
N-PDZ1–2S (AAA N-PDZ1–2S) were co-
transfected with or without p35-cdk5 in
COS-7 cells (Fig. 4D). AAA PSD-95 was
immunoprecipitated by an antibody
raised against the SH3 domain of PSD-95
Figure 4. Phosphorylation of the N-terminal domain of PSD-95 by cdk5 reduces PSD-95 multimerization but not ion channel
binding. A, top, Coimmunoprecipitation of phosphorylated PSD-95 with Kv1.4 channel. Kv1.4 antibody was used to coimmuno-
precipitate PSD-95 from lysates of COS-7 cells cotransfected with PSD-95 (N-PDZ1–2S) and Kv1.4, in the presence (or absence) of
p35-cdk5, or with inactive cdk5 (DNcdk5). Monoclonal PSD-95 antibody was used to detect PSD-95. The slow PSD-95 mobility
band is diagnostic of phosphorylation. Kv1.4, cdk5, and p35 antibodies were used as controls. Bottom, Coimmunoprecipitation of
phosphorylated PSD-95 with NMDA receptor. NR2B antibody was used to coimmunoprecipitate PSD-95 from synaptosomal
lysates. PSD-95 and cytochrome c (Cyt C) antibodies were used as controls. Phospho-T19S25 and monoclonal PSD-95 antibodies
were used to detect phosphorylated and total PSD-95, respectively. B, Effect of phosphorylation by cdk5 on coimmunoprecipita-
tion of PSD-95. Myc-PSD-95 was immunoprecipitated with anti-Myc antibody from lysates of COS-7 cells expressing N-PDZ1–2S
and Myc-tagged full-length PSD-95 with (or without) p35-cdk5. The immunoprecipitates were blotted with anti-PSD-95 anti-
body. N-PDZ1–2S and Myc-tagged full-length PSD-95 proteins were identified by their differential mobility on SDS-PAGE. The
blot was subsequently probed with p35 and cdk5 antibodies. Input lanes were loaded with 10% of lysates. C, Effect of phosphor-
ylation by cdk5 on coimmunoprecipitation of HA- and Myc-tagged PSD-95. Myc-PSD-95 was immunoprecipitated with anti-Myc
antibody from lysates of COS-7 cells expressing HA- and Myc-tagged full-length PSD-95 with (or without) p35-cdk5. The immu-
noprecipitates were blotted with anti-HA antibody, and subsequently probed with Myc, p35, and cdk5 antibodies. Input lanes
were loaded with 10% of lysates. D, Coimmunoprecipitation of the alanine mutants of PSD-95. Full-length PSD-95 was immuno-
precipitated with the CSK antibody from lysates of COS-7 cells expressing the triple alanine mutant (T19A, S25A, S35A) of
N-PDZ1–2S and full-length PSD-95. CSK antibody was raised against the SH3 domain of PSD-95 and does not recognize N-PDZ1–
2S. The immunoprecipitates were blotted with anti-PSD-95 antibody. N-PDZ1–2S and full-length PSD-95 were identified by their
differential mobility on SDS-PAGE. The blot was subsequently probed with p35, and cdk5 antibodies. Input lanes were loaded with
10% of lysates.
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(Hsueh and Sheng, 1999). AAA N-PDZ1–2S coimmunoprecipi-
tated with AAA PSD-95 regardless of p35-cdk5 expression (Fig.
4D). Together, these experiments provide evidence that phos-
phorylation of the N-terminal domain of PSD-95 by p35-cdk5
reduces PSD-95 multimerization.
Phosphorylation of PSD-95 regulates clustering of PSD-95
and ion channels in COS-7 cells
PSD-95 is a scaffolding protein that anchors NMDAR at syn-
apses. In heterologous cells, the coexpression of PSD-95 with ion
channels such as Kv1.4 and NMDAR induces their coclustering
(Kim et al., 1995; Kim and Sheng, 1996). The truncated form of
PSD-95, N-PDZ1–2S, has been shown to cluster Kv1.4 as effec-
tively as full-length PSD-95 (Hsueh et al., 1997). To explore the
possibility that phosphorylation of PSD-95 by p35-cdk5 regulates
the clustering of PSD-95 and ion channels, COS-7 cells were
cotransfected with N-PDZ1–2S, Kv1.4, and either GFP alone,
p35-cdk5-GFP, or inactive kinase (DNcdk5-GFP) (Nikolic et al.,
1996, 1998) (Fig. 5A). As predicted, 72% of COS-7 cells coex-
pressing Kv1.4 and N-PDZ1–2S displayed coclustering of
PSD-95 and Kv1.4 (Fig. 5A, a– d). However, only 3.2% of cells
cotransfected with p35-cdk5-GFP displayed immunostained
clusters of PSD-95 and Kv1.4 (Fig. 5A, e– h). Consistent with
these results, 68% of transfected cells expressing DNcdk5-GFP
showed clusters of PSD-95 and Kv1.4 (Fig. 5A, i–l). The scoring
and quantification of these experiments was performed in a blind
manner. The images were taken focusing on the cell surface and
the PSD-95 clusters colocalize with the Kv1.4 clusters, suggesting
a surface expression of these clusters, although we cannot exclude
the possibility that some of these clusters may not be at the cell
surface. Together, these results suggest that phosphorylation of
PSD-95 by cdk5 reduces coclustering of PSD-95 and ion channels
in heterologous cells. To further address whether N-terminal
phosphorylation of PSD-95 is responsible for the observed reduc-
tion of clustering, the triple alanine mutant of truncated PSD-95
(T19A, S25A, S35 NPZ1–2S) and Kv1.4 were expressed in COS-7
cells with, or without, p35-cdk5-GFP (Fig. 5B). Like the wild-type
protein, the triple alanine mutant of PSD-95 formed clusters with
Kv1.4 (Fig. 5B, a– c). However, unlike the wild-type PSD-95 pro-
tein, expression of p35-cdk5 did not affect the clustering of mu-
tant PSD-95 and Kv1.4 (Fig. 5B, d–f). These data argue for a role
of phosphorylation of the N-terminal domain of PSD-95 by p35-
cdk5 in the regulation of coclustering of PSD-95 and neuronal
ion channels.
Cdk5/ embryonic cortical neurons display enhanced
PSD-95 clusters
To evaluate clustering of PSD-95 in mice lacking cdk5 activity,
the PSD-95 staining pattern was analyzed in cultured cortical
neurons derived from cdk5/ and wild-type littermates.
Cdk5/ mice are perinatal lethal, and the neurons derived
from them do not thrive in low-density long-term cultures. To
analyze the PSD-95 clusters in these mice, cortical neurons were
cultured for 4 DIV. Although synaptogenesis is still active in these
young cultures and most of the synapses are not yet fully formed,
larger PSD-95 immunostained clusters were observed in
cdk5/ neurons (Fig. 6A, b,d) compared with wild-type cul-
tures (Fig. 6A, a,c). The areas of PSD-95 immunostaining were
quantified blind and rendered in number of pixels. In wild-type
neurons, small PSD-95 clusters (10 –30 pixels) were 75.82% of
total clusters (SEM, 5.50%) versus the 43.53% (SEM, 10.98%)
observed in cdk5/ neurons (Fig. 6B). Conversely, larger clus-
ters were more frequent in cdk5/ than in wild-type neurons.
Figure 5. Active p35-cdk5 reduces the clustering of PSD-95 and ion channels in COS-7 cells.
A, Clustering of PSD-95 and Kv1.4 in COS-7 cells. a– d, COS-7 cells cotransfected with PSD-95
(N-PDZ1–2S), K ion channel (Kv1.4) and GFP ( a) were immunostained for Kv1.4 ( b) and
PSD-95 ( c). d, Merged b and c. The immunostaining is representative of 72% of transfected cells.
e– h, COS-7 cells cotransfected with N-PDZ1–2S, Kv1.4, p35, and cdk5-GFP ( e) were immuno-
stained for Kv1.4 ( f) and PSD-95 ( g). h, Merged f and g. The immunostaining is representative
of 96.8% of transfected cells. i–l, COS-7 cells cotransfected with N-PDZ1–2S, Kv1.4, and domi-
nant negative cdk5-GFP (DNcdk5-GFP, inactive kinase, i) were immunostained for Kv1.4 ( j) and
PSD-95 ( k). l, Merged j and k. The immunostaining is representative of 68% of transfected cells.
Immunofluorescence images were taken by Delta Vision microscopy. Scale bars, 10 m. B,
Clustering of the T19A, S25A, S35A truncated PSD-95 mutant and Kv1.4 in COS-7 cells. a– c,
COS-7 cells cotransfected with the T19A, S25A, T19A mutant PSD-95 (N-PDZ1–2S), Kv1.4, p35,
and cdk5-GFP ( a) were immunostained for Kv1.4 ( b) and PSD-95 ( c). d–f, COS-7 cells cotrans-
fected with the T19A, S25A, S35A mutant N-PDZ1–2S, Kv1.4, and GFP ( d) were immunostained
for Kv1.4 ( e) and PSD-95 ( f). Immunofluorescence images were taken by Delta Vision micros-
copy. Scale bars, 10m.
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PSD-95 clusters ranging in size from 31 to 60 pixels, 61 to 90
pixels, and clusters larger than 91 pixels constituted, respectively,
17.86% (SEM, 3.33%), 5.40% (SEM, 1.71%), and 0.90% (SEM,
0.09%) of total clusters in wild-type neurons, compared with
33.73% (SEM, 3.75%), 11.54% (SEM, 1.98%), and 11.18%
(SEM, 5.3%) in cdk5/neurons (Fig. 6B). Together, these data
argue for a regulatory role of cdk5 activity on the clustering of
PSD-95 in neurons.
Expression of inactive cdk5 (DNcdk5) in hippocampal
neurons induces larger PSD-95 clusters
To further determine whether cdk5 affects the synaptic clustering
of PSD-95, rat hippocampal neurons were infected with recom-
binant HSV expressing DNcdk5-GFP (Fig. 7A, a– c), or LacZ (Fig.
7A, d–f). The infection efficiencies were 30 –70% as detected by
either GFP or LacZ immunostaining. Clustering of PSD-95 was
scored double-blind. PSD-95 immunostained clusters were de-
tected in both DNcdk5- and LacZ (control)-expressing neurons;
however, there was a notable shift toward larger clusters in
DNcdk5 relative to LacZ-expressing neurons. In neurons ex-
pressing DNcdk5, an increase in the number of large PSD-95
clusters paralleled a reduction in small clusters (Fig. 7A, a– c)
compared with the size distribution of clusters in LacZ-infected
neurons (Fig. 7A, d–f). The size of PSD-95 clusters was quantified
as described above. In the LacZ-expressing neurons, 66.18% clus-
ters (SEM, 4.96%) were 100 –200 pixels in size, whereas only
44.03% (SEM, 3.23%) clusters of this size were found in DNcdk5-
infected neurons (Fig. 7B). Conversely, in LacZ-infected neu-
rons, 11.62% (SEM, 1.16%) clusters were400 pixels, compared
with 35.86% (SEM, 0.82%) in neurons expressing DNcdk5 (Fig.
7B). Therefore, DNcdk5-GFP expression in neurons resulted in a
shift from small to large clusters of PSD-95, consistent with the
observation that cdk5/ cortical neurons displayed larger
PSD-95 than wild-type neurons. Together, these observations are
supportive of a correlation between the increase in size of PSD-95
clusters and the loss of cdk5 activity. In mature synapses, the
NMDARs are clustered by PSD-95. To determine whether
the increase in PSD-95 cluster size was paralleled by an in-
crease in the size of NMDAR clusters, the hippocampal neurons
expressing DNcdk5 or LacZ were immunostained with an anti-
body against NR1, a subunit of the NMDAR (Fig. 7C). In LacZ-
or DNcdk5-expressing neurons, PSD-95 clusters were positive
for NR1, consistent with the notion that DNcdk5 expression does
not affect the association of NMDAR with PSD-95. This result
also supports the hypothesis that cdk5 activity regulates cluster-
ing of PSD-95 and NMDAR at synapses.
Expression of the triple alanine mutant of PSD-95 (T19A,
S25A, S35A) in hippocampal neurons induces larger
PSD-95 clusters
To discriminate between a direct effect of cdk5 phosphorylation
of the N-terminal domain of PSD-95 and other effects of cdk5
and to determine whether N-terminal phosphorylation of
PSD-95 is responsible for the observed reduction of clustering,
rat hippocampal neurons were transfected with the triple alanine
mutant (T19A, S25A, S35) of full-length PSD-95 (Fig. 8A, a), or
wild-type full-length PSD-95 (Fig. 8A, b). Clustering of PSD-95
was scored double-blind. A general increase in cluster size was
observed under both conditions, compared with the untrans-
fected neurons, consistent with previous observations indicating
a role of PSD-95 in the maturation of excitatory synapses (El-
Husseini et al., 2000b). Interestingly, a modest but statistically
significant increase in the cluster size was detected in neurons
expressing the triple alanine mutant of PSD-95 compared with
neurons expressing transfected wild-type PSD-95. The size of
PSD-95 clusters was quantified as described above. In neurons
expressing wild-type PSD-95, 51.07% clusters (SEM, 2.27%)
were 10 –30 pixels in size, whereas only 45.25% (SEM, 1.53%)
clusters of this size were found in neurons expressing mutant
Figure 6. Cortical cdk5/ neurons display larger PSD-95 clusters. A, PSD-95 clusters in
cortical neurons (4 DIV). Cortical neurons derived from wild-type (WT, a, c) and cdk5/ (b, d)
E16.5 littermate embryos cultured for 4 DIV and immunostained for PSD-95 (green in a, b; c, d
represent green channel only). Nuclei were stained with TOTO-3 (blue). Immunofluorescence
images were taken by confocal microscopy. Scale bars, 10 m. B, Morphometric analysis of
areas of PSD-95 immunoreactivity in wild-type and cdk5/ dendrites of cortical neurons
and the frequency distribution of PSD-95 cluster areas as expressed in number of pixels. *Sta-
tistically significant differences between the wild-type and the cdk5/ neurons.
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PSD-95 (Fig. 8B). Conversely, in neurons transfected with wild-
type PSD-95, 15.50% (SEM, 1.33%) and 4.81% (SEM, 0.69%) of
clusters were 61–120 pixels and 120 pixels respectively, com-
pared with 19.05% (SEM, 1.11%) and 5.01% (SEM, 0.88%) in
neurons expressing mutant PSD-95 (Fig. 8B). Consistent with
the observations that cdk5/ cortical neurons and neurons
expressing DNcdk5 displayed larger PSD-95 clusters than wild-
type neurons, the expression of the triple alanine mutant of
PSD-95 resulted also in a shift to larger clusters of PSD-95. To-
Figure 7. Expression of inactive cdk5 (DN-cdk5) in hippocampal cultures affects the cluster-
ing of PSD-95. A, a, GFP immunostaining of a neuron overexpressing DN-cdk5-GFP. Hippocam-
pal neurons were cultured for 14 DIV, infected with HSV-DNcdk5-GFP, and immunostained for
GFP. b, PSD-95 and GFP coimmunostaining of a neuron expressing DN-cdk5-GFP. A dendrite of
HSV-DNcdk5-GFP infected hippocampal neurons immunostained for GFP (green) and PSD-95
(red). c, PSD-95 immunostaining of a neuron expressing DN-cdk5-GFP (red channel). d,-Gal
immunostaining of a neuron overexpressing LacZ. DIV 14 hippocampal neurons infected with
HSV-LacZ and immunostained for-Gal. e, PSD-95 and-Gal coimmunostaining of a neuron
expressing LacZ. A dendrite of HSV-LacZ infected hippocampal neurons immunostained for
-Gal (green) and PSD-95 (red). f, PSD-95 immunostaining of a neuron expressing LacZ (red
channel). Scale bars, 10m. B, Morphometric analysis of areas of PSD-95 immunoreactivity in
neurons infected with DNcdk5-GFP or LacZ and the frequency distribution of PSD-95 immuno-
reactive clusters. *Statistically significant differences between the HSV-DNcdk5-GFP versus
Figure 8. Expresssion of the triple alanine mutant (T19A, S25A, S35A) of PSD-95 in hip-
pocampal cultures affects the clustering of PSD-95. A, a, PSD-95 immunostaining of a neuron
expressing mutant PSD-95. Hippocampal neurons were cultured for 14 DIV, cotransfected with
the triple alanine mutant (T19A, S25A, S35A) of full-length PSD-95 and GFP, and immuno-
stained for PSD-95. b, PSD-95 immunostaining of a neuron expressing wild-type PSD-95. Scale
bars, 10m. B, Morphometric analysis of areas of PSD-95 immunoreactivity in neurons trans-
fected with mutant or wild-type PSD-95 and the frequency of distribution of PSD-95 immuno-
reactive cluster size. *Statistically significant differences between neurons expressing mutant
versus wild-type PSD-95, as defined by the unpaired t test.
4
the HSV-LacZ infected neurons, as defined by the unpaired t test. C, PSD-95 and NR1 immuno-
staining of infected neurons. Dendrites of hippocampal neurons infected with HSV-LacZ (left) or
HSV-DNcdk5-GFP (right). Left, -Gal immunostaining (top), PSD-95 (red) and NR1 (green)
immunostaining. Right, GFP immunostaining (top), PSD-95 (red) and NR1 (green) immuno-
staining. Scale bars, 10m.
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gether, these observations support the model that phosphoryla-
tion of PSD-95 by cdk5 regulates the clustering of PSD-95 in
neurons.
Discussion
PSD-95 has been involved in coupling the NMDARs to pathways
that regulate synaptic plasticity and learning (Migaud et al.,
1998). Recently, cdk5 activity has also been proposed to contrib-
ute to synaptic plasticity, learning, and memory (Li et al., 2001).
We report here that PSD-95 is phosphorylated in vivo in a cdk5-
dependent manner, and that inhibition of cdk5 activity in neu-
rons results in enlargement of PSD-95 clusters. These findings
indicate that phosphorylation by cdk5 plays a regulatory role in
the clustering of PSD-95 and suggest that cdk5 may contribute to
the regulation of excitatory synapse formation and plasticity.
PSD-95 is an in vitro substrate of cdk5
In this study, we demonstrate that cdk5 phosphorylates PSD-95
in vitro and in vivo. Recombinant cdk5 readily phosphorylates the
N-terminal domain of PSD-95 in vitro. The specificity of
the kinase reaction is upheld by the stoichiometry of 0.86
and the increase of  32P ATP incorporation observed by either
increasing reaction time or amount of substrate.
Phosphorylated PSD-95 is present in vivo at PSD
To evaluate the phosphorylation of the T19 and S25 residues in
vivo, we generated a phospho-epitope-specific antibody,
phospho-T19S25. Western blot analysis using the phospho-
T19S25 antibody revealed that phosphorylated PSD-95 is present
in synaptosomes and in PSD fractions. The slower-migrating spe-
cies observed in SDS-PAGE of synaptosome lysates is not de-
tected by the phospho-T19S25 antibody and could represent the
N-terminal alternative spliced isoform of PSD-95 (Chetkovich et
al., 2002). The N-terminal domain of this higher-molecular-
weight isoform lacks the cdk5 consensus sites, but includes an
“L27” motif (Chetkovich et al., 2002), which is also present in
SAP97/human discs-large (Lue et al., 1994; Muller et al., 1995), a
related MAGUK protein. The hypothesis that PSD-95 is a physi-
ological substrate of cdk5 is further supported by the drastically
reduced phosphorylation of T19 and S25 in brain lysates derived
from cdk5/mutant mice.
Phosphorylated PSD-95 is present in PSD fractions together
with p35 and cdk5, supporting a role for the cdk5-dependent
phosphorylation of PSD-95 in synaptic function. The N terminal
of PSD-95 is essential for PSD-95 multimerization, membrane
association, and clustering of PSD-95 and neuronal ion channels
(Topinka and Bredt, 1998; Hsueh and Sheng, 1999). We find that
the ability of PSD-95 to associate to membranes is decreased on
phosphorylation of its N-terminal domain, possibly because of
alteration in its structure or the addition of charges to this very
critical domain. The N-terminal domain of PSD-95 contains two
residues, cysteines 3 and 5 that are sites of palmitoylation; this
modification is thought to be essential for membrane association
and ion channel binding (Topinka and Bredt, 1998). Mutations
in cysteines 3 and 5 abolish the ability of PSD-95 to self-associate
and to cluster ion channels (Hsueh and Sheng, 1999). It is possi-
ble that phosphorylation by cdk5 may interfere with the ability of
PSD-95 to be palmitoylated or it may constitute an additional
mechanism by which the N terminal can be post-translationally
modified. Interestingly, the N-terminal domain of SAP97 does
not have cysteine residues and also lacks cdk5 consensus phos-
phorylation sites, whereas the N-terminal domain of other syn-
aptic MAGUKs, such as Chapsyn-110/PSD-93 (Brenman et al.,
1996b; Kim et al., 1996), and SAP102 (Muller et al., 1996) include
the conserved cysteine residues and potential cdk5 phosphoryla-
tion sites. It is possible that phosphorylation may be a conserved
regulatory mechanism among this group of synaptic MAGUKs.
Phosphorylation of PSD-95 affects its ability to multimerize
but does not have an impact on binding to ion channels
The N-terminal domain of PSD-95 is thought to be involved in
PSD-95 multimerization. We show here that the ability of
PSD-95 to self-associate into multimers, as detected by coimmu-
noprecipitation from COS-7 cell lysates, is markedly reduced on
phosphorylation of the N-terminal domain of PSD-95 by cdk5.
We performed these experiments using either two differentially
tagged forms of PSD-95, or full-length PSD-95 together with a
truncated form of PSD-95, distinguishable by electromobility. In
all cases, the coexpression of PSD-95 with cdk5 reduced the abil-
ity of PSD-95 to self-associate. Consistent with this data, the mul-
timerization of the alanine mutant of the phosphorylation sites
(T19A, S25A, S35) was not affected by the expression of p35-
cdk5, suggesting that the phosphorylation of the N-terminal do-
main of PSD-95 reduces its self-association. Multimerization has
been proposed as one of the mechanisms that regulates the ion
channels clustering and scaffolding functions of PSD-95. We
propose that cdk5-dependent phosphorylation of PSD-95 is an
additional mechanism by which these functions are regulated.
PSD-95 binds the NR2 subunits of the NMDAR and clusters
them at synapses. Our study indicates that phosphorylation of the
N-terminal domain of PSD-95 by cdk5 does not prevent PSD-95
binding to Kv1.4 in COS-7 cells. Furthermore we observed that,
in synaptosomes, phosphorylated PSD-95 associates with NR2B,
a NMDAR subunit that binds PSD-95. Together, our results sup-
port the notion that multimerization and ion channel binding are
two separate functions of PSD-95.
Clustering of PSD-95 and ion channels is reduced by active
cdk5 in heterologous cells
The N-terminal domain of PSD-95 is essential for neuronal ion
channel clustering, an important mechanism for maximizing re-
sponses to neurotransmitter release. Previous studies indicated
that deletion mutants of PSD-95 lacking the N-terminal domain
are unable to cluster Kv1.4 (Hsueh et al., 1997). We tested the
ability of cdk5 to regulate PSD-95 and ion channel clustering in
COS-7 cells. Indeed this assay revealed that clustering of both
PSD-95 and Kv1.4 is remarkably disrupted in the presence of
p35-cdk5, but not DNcdk5. The significance of phosphorylation
of the N-terminal domain of PSD-95 on clustering is revealed by
the ability of the triple alanine PSD-95 mutant (T19A, S25A, S35)
to form clusters independently of p35-cdk5 expression. The
smaller size of clusters observed with these mutants is possibly
caused by structural changes in the N-terminal domain of
PSD-95 that could affect its ability to bind membranes. Nonethe-
less, the expression of alanine PSD-95 mutant with p35-cdk5
results in visible clusters, whereas wild-type PSD-95 and p35-
cdk5 expression does not yield detectable clusters. This result is
consistent with the possibility that phosphorylation of PSD-95 by
p35-cdk5 regulates coclustering of PSD-95 and neuronal ion
channels.
Clustering of PSD-95 is increased in cdk5/
cortical neurons
Postsynaptic clustering is critical in both synaptogenesis and
plasticity. During synapse formation, clustering of PSD-95 oc-
curs early and may play a primary role in organizing and localiz-
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ing proteins to the PSD. PSD-95 is trafficked on dendritic endo-
membranes (El-Husseini et al., 2000a) and clusters at dendrites
before its interaction with synaptic glutamate receptors (Rao et
al., 1998). The N-terminal domain of PSD-95 has been impli-
cated in the synaptic targeting of PSD-95. We evaluated PSD-95
clusters in young cortical cultures derived from cdk5/ and
wild-type embryonic mice littermates. The quantification of the
cluster size reveals a shift toward larger clusters in cdk5/ neu-
rons. Because the cultures used are relatively young (only 4 DIV),
the PSD-95 staining observed may reflect different stages of syn-
aptic maturation and synaptic targeting of PSD-95. Nevertheless,
these observations support a role of cdk5 in the regulation of
clustering of PSD-95 in neurons.
Expression of inactive cdk5 (DNcdk5) or triple alanine
mutant PSD-95 induces larger PSD-95 clusters
We investigated the acute effect of inhibition of cdk5 activity on
mature synapses in hippocampal cultures. In these neurons, the
overexpression of inactive cdk5 (DNcdk5) caused an increase in
the size of PSD-95 clusters along the dendrites, indicating a de-
regulation of PSD-95 and NMDAR clustering in the absence of
cdk5 activity. We tested the direct effect of the cdk5-dependent
phosphorylation of the N-terminal domain of PSD-95 on clus-
tering by expressing the triple alanine mutant of PSD-95 in neu-
rons and comparing the PSD-95 clusters to those in neurons
expressing wild-type PSD-95. Consistent with the analysis of
cdk5/ neurons and DNcdk5-expressing neurons, we ob-
served an increase in cluster size along the dendrites of neurons
expressing mutant PSD-95. The effect was small but statistically
significant. The smaller effect observed in neurons expressing
mutant PSD-95 compared with those expressing DNcdk5 could
be attributed to other effects that cdk5 activity may have on the
trafficking and targeting of PSD-95 and/or simply to the presence
in these neurons of wild-type PSD-95, which is still able to be
phosphorylated by cdk5 and thus may reduce the effect of mutant
PSD-95. An additional possibility is that the other three potential
phosphorylation sites in PSD-95 (not characterized in this study)
may contribute to the formation of PSD-95 clusters and their
stability. Although cdk5 activity may also have a direct impact on
the formation of PSD-95 clusters, our observations suggest that
cdk5-dependent phosphorylation of PSD-95 may regulate the
size of the PSD dynamically. Dynamic changes in distribution
and density of neuronal ion channels and receptors, and alter-
ations in PSD structure, may play a role in synaptic plasticity
(Geinisman et al., 1991; Okabe et al., 1999; Marrs et al., 2001).
PSD-95 has emerged as a major player in targeting and clustering
proteins at synapses and has been described as an itinerant pro-
tein (El-Husseini et al., 2000a). Interactions between the PSD-95
complex and molecular motors such as myosin-V or dynein
(Naisbitt et al., 2000; Walikonis et al., 2000) may provide a driv-
ing force for PSD movements. Together, these observations sup-
port the hypothesis that clustering of PSD-95 may also be dy-
namic. Studies of the Drosophila neuromuscular junction
indicate that calcium– calmodulin-dependent protein kinase II
(CaMKII) phosphorylation regulates the distribution of the syn-
aptic MAGUK Discs Large (DLG), which consequently has an
impact on synaptic structure (Koh et al., 1999). Constitutive ac-
tivation of CaMKII induces a diffuse pattern of DLG immuno-
staining extended to extrasynaptic regions, suggesting that an-
choring of DLG at synapses is optimal when DLG is in the
dephosphorylated state. Similarly, we find that inactivation of
cdk5 in hippocampus neurons results in increased PSD-95 clus-
ter size, suggesting that cdk5 may regulate clustering of PSD-95 at
synapses. Inhibition of cdk5 activity by roscovitine blocks both
LTP induction and NMDA-evoked currents in CA1 hippocam-
pal neurons (Li et al., 2001). It is likely that the change in cluster-
ing of PSD-95 and NMDARs (resulting from the inhibition of
cdk5 activity) may contribute to the block of LTP induction.
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